Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.85 USD | +15.51% | +27.09% | -63.37% |
10/05 | Annovis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/05 | Annovis Bio, Inc. Announces Unblinding of the Buntanetap Phase III Data in Parkinson?s Disease | CI |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- Press Releases